SCHEMBL9230792

SCHEMBL9230792

O=S(=O)(CS(=O)(=O)c1c(F)c(F)c(F)c(F)c1F)c1c(F)c(F)c(F)c(F)c1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 14/20 0.48
CA2 P00918 14/20 0.48
CA12 O43570 7/20 0.48
CA7 P43166 7/20 0.48
CA13 Q8N1Q1 7/20 0.48
CA9 Q16790 4/20 0.43
CA3 P07451 2/20 0.43
CA4 P22748 2/20 0.43
CA6 P23280 2/20 0.43
CA5A P35218 2/20 0.43
CA14 Q9ULX7 2/20 0.43
CA5B Q9Y2D0 2/20 0.43
MMP1 P03956 1/20 0.42
MMP2 P08253 1/20 0.42
MMP9 P14780 1/20 0.42
MMP8 P22894 1/20 0.42
MMP13 P45452 1/20 0.42
F2 P00734 3/20 0.37
PRSS1 P07477 3/20 0.37
PRSS2 P07478 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20411809 0.84 CA1 (0.40) CA1CA2CA12CA7CA13
SCHEMBL775994 0.79 CA1 (0.46) CA1CA2CA12CA7CA13
SCHEMBL2312881 0.75 CA1 (0.43) CA1CA2CA12CA7CA13
SCHEMBL776950 0.73 CA1 (0.40) CA1CA2CA12CA7CA13
SCHEMBL777768 0.69 CA1 (0.56) CA1CA2CA12CA7CA13
SCHEMBL13659417 0.69 CA1 (0.56) CA1CA2CA12CA7CA13
SCHEMBL2477379 0.67 CA1 (0.53) CA1CA2CA12CA7CA13
SCHEMBL764972 0.67 CA1 (0.53) CA1CA2CA12CA7CA13
SCHEMBL20226553 0.66 CA1 (0.41) CA1CA2CA12CA7CA13
SCHEMBL571331 0.65 CA1 (1.00) CA1CA2CA12CA7CA13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240021874-A1 Sulfonimide Salts for Battery Applications MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2024-01-18 US disclosed
US-20180212275-A1 SULFONIMIDE SALTS FOR BATTERY APPLICATIONS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2018-07-26 US disclosed
US-5446134-A Reacting bis(fluorosulfonyl)methane salt with cyanogen halide or pseudohalide CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 1995-08-29 US disclosed
EP-0567637-A1 BIS(PERFLUOROSULPHONYL)METHANES, PROCESS FOR PREPARING SAME AND USES THEREOF Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1993-11-03 EP disclosed
WO-1993009092-A1 BIS(PERFLUOROSULPHONYL)METHANES, PROCESS FOR PREPARING SAME AND USES THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 1993-05-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180212275-A1 SULFONIMIDE SALTS FOR BATTERY APPLICATIONS TST, EWSR1, SCLY CA1 526/4885CA2 516/4885CA12 300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.